Search results
AstraZeneca's (AZN) Imfinzi Combo Meets Liver Cancer Study Goal
Zacks via Yahoo Singapore Finance· 5 months agoData from a late-stage shows that AstraZeneca's (AZN) cancer combination therapy reduces the risk of...
Merck (MRK), Seagen Drug Combo Gets FDA Nod for Bladder Cancer
Zacks via Yahoo Singapore Finance· 1 year agoThe combination of Merck's (MRK) Keytruda and Seagen's (SGEN) Padcev is the first approved...
Merck's (MRK) Keytruda-Lynparza Combo Fails Lung Cancer Study
Zacks via Yahoo Singapore Finance· 7 months agoAfter a late-stage study fails to show any improvement in its primary endpoints, Merck (MRK) decides...
Roche (RHHBY) Announces Data on Tecentriq Combo for HCC
Zacks via Yahoo Singapore Finance· 1 year agoRoche's (RHHBY) new data from the late-stage IMbrave050 study reveals that the combination of...
Roche (RHHBY) Polivy Combo Backed by FDA Advisory Committee
Zacks via Yahoo Singapore Finance· 1 year agoRoche (RHHBY) gets majority votes from the FDA's Advisory Committee for Polivy combination for the...
Merck (MRK) Keytruda Studies in Difficult-to-Treat Cancers Fail
Zacks via Yahoo Singapore Finance· 1 year agoMerck (MRK) and Eisai announce the discontinuation of the phase III LEAP-003 study seeking approval...
Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
Zacks via Yahoo Singapore Finance· 1 month agoThis week, Bayer BAYRY released its first-quarter results. J&J JNJ announced that it will acquire a...
AstraZeneca (AZN) Q4 Earnings Beat, Sales Hurt by COVID Jab
Zacks via Yahoo Singapore Finance· 1 year agoAstraZeneca’s AZN fourth-quarter 2022 core earnings of 69 cents per American depositary share (ADS)...
Merck's (MRK) Keytruda for Liver Cancer to Undergo FDA Review
Zacks via Yahoo Singapore Finance· 1 year agoFDA accepts Merck's (MRK) supplemental biologics license application for Keytruda plus chemotherapy...
QuidelOrtho Corporation (NASDAQ:QDEL) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 4 months agoQuidelOrtho Corporation (NASDAQ:QDEL) Q4 2023 Earnings Call Transcript February 13, 2024 QuidelOrtho...